EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015, the company is focused on creating safe, scalable, and accessible therapies that eliminate traditional barriers to CAR-T treatment. Headquartered in West Palm Beach, Florida with operations across the Cayman Islands and Asia, EXUMA takes a globally integrated approach to science and development. Our mission is to create safe, effective, and accessible therapies through platforms designed for high-throughput discovery, tumor-specific targeting, and point-of-care delivery.
| Website | http://www.exumabio.com |
| Revenue | $4 million |
| Employees | 26 (17 on RocketReach) |
| Founded | 2015 |
| Address | 625 N Flagler Dr, West Palm Beach, Florida 33401, US |
| Phone | +1 345-232-0566 |
| Fax | (561) 660-7914 |
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering |
| Keywords | Cell Therapy, Gene Therapy, Cancer Treatment, Oncology, Biotechnology, Clinical Stage, Immunotherapy, Cell Therapies, Cancer Therapies, Gene Editing, Precision Medicine, Pharmaceutical, Biopharma, Drug Development, Clinical Trials, Regenerative Medicine, Molecular Biology, Biomedical Research, Pharmaceutical Research |
| Competitors | Amgen, Genentech, Regeneron, Vertex Pharmaceuticals, Sangamo Therapeutics, Inc., Biogen, Novartis, Lilly India, Pfizer, Gilead Sciences +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular EXUMA Biotech employee's phone or email?
The EXUMA Biotech annual revenue was $4 million in 2026.
Gregory Frost is the Chairman and CEO of EXUMA Biotech.
17 people are employed at EXUMA Biotech.
EXUMA Biotech is based in West Palm Beach, Florida.
The NAICS codes for EXUMA Biotech are [541, 5417, 541711, 54171, 54].
The SIC codes for EXUMA Biotech are [28, 283].